Cargando…
Modulating Dickkopf-1: A Strategy to Monitor or Treat Cancer?
Dickkopf-1 (DKK1) is a secreted Wnt/β-catenin pathway antagonist involved in embryogenesis. It was first described 25 years ago for its function in head induction and limb morphogenesis. Since then, this protein has been widely studied in the context of active Wnt/β-catenin signalling during cellula...
Autores principales: | Mazon, Mélody, Masi, Delphine, Carreau, Madeleine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4963804/ https://www.ncbi.nlm.nih.gov/pubmed/27367730 http://dx.doi.org/10.3390/cancers8070062 |
Ejemplares similares
-
Elevated blood levels of Dickkopf‐1 are associated with acute infections
por: Mazon, Melody, et al.
Publicado: (2018) -
Rationale for targeting the Wnt signalling modulator Dickkopf‐1 for oncology
por: Kagey, Michael H, et al.
Publicado: (2017) -
The Clinical Diagnostic and Prognostic Value of Dickkopf-1 in Cancer
por: Li, Jie, et al.
Publicado: (2020) -
Prognostic role of dickkopf-1 in patients with cancer
por: Huang, Junfang, et al.
Publicado: (2020) -
Dickkopf-1: A Promising Target for Cancer Immunotherapy
por: Chu, Hang Yin, et al.
Publicado: (2021)